Numerate, which collaborates with Merck ($MRK) and others with its computer-based drug design platform, isn't the only group from the biotech realm hooked into Google's cloud. Seattle's Institute for Systems Biology has tapped the cloud platform to tackle research involving big data, which includes huge amounts of biological data that can easily overwhelm computer storage and processors.
We were very excited to watch the live stream of the keynote from the Google I/O conference today, because it featured work from ISB's Shmulevich Lab, which is one of a group of research organizations that has been working on The Cancer Genome Atlas (TCGA).
During the Google IO keynote, Urs Hölzle, Senior Vice President of Infrastructure at Google, introduced Google Compute Engine, an infrastructure-as-a-service product that lets businesses and researchers tap into the scalability, power, and efficiency of Google’s data centers using virtual machines.
The nonprofit Institute for Systems Biology is one of two dozen research centers taking part in a national project to map genetic changes in 20 types of cancer. Using Google Compute Engine, researchers are able to tap into the vast computational power of Google's data center to analyze complex cancer data sets in a fraction of the time, spurring hope that new treatments and cures can be found more quickly.
Google is taking direct aim at Amazon.com in tablets, with yesterday’s announcement of the Nexus 7. Today, it is a completely different area where the tech titans are lining up for a fight.
...According to Engadget, Google is promising “50 percent more computes per dollar” than its rivals. (Pricing details here). It wasn’t lost on us that Google touted a Seattle-based organization — Lee Hood’s Institute for Systems Biology — as one of the users of the new service at the Google I/O conference.
Dr. Baliga has also made significant contributions to high school science education throughout Washington and many other states through founding the program Systems Education Experiences (SEE). His primary goal is to develop mind-stimulating lessons that will prepare a new generation of scientists and empower all people to better understand today’s science and health.
Stephen Hawking is a scientific rock star, we all know that. But what is surprising is the youth of the 70-year-old physicist’s fan base. Before his lecture in Seattle this weekend, pre-teen boys and girls pressed against a velvet rope in the gilded lobby of the Paramount Theater, hoping to catch a glimpse or maybe even snap a picture of him.
British physicist Stephen Hawking has lived longer and achieved more than most quadriplegics have, but he's not done yet: The 70-year-old theoretician is still waiting for experimental evidence to launch him toward a Nobel Prize.